Geintourinary malignancies in children: editorial comment.

Pediatric Urology, Hospital for Sick Children, University of Toronto, 555 University Avenue, Toronto, Ontario M5G 1X8, Canada.
Pediatric Clinics of North America (Impact Factor: 2.2). 08/2012; 59(4):961-4. DOI: 10.1016/j.pcl.2012.05.017
Source: PubMed

ABSTRACT The modern management of pediatric genitourinary malignancies has resulted in survival rates that are dramatically better than figures from just a few decades ago. This is largely due to advances in multimodal treatment, collaborative efforts, and multidisciplinary management. Nevertheless, issues related to long-term side effects, treatment-related morbidity, and progression or recurrences remain important and pressing in terms of research directions and areas for improvement. In this Editorial Comment the author attempts to employ the current state of the art, masterfully summarized in the accompanying review by Drs Grimsby and Ritchey, to provide a view of trends that are likely to become increasingly important in the future, highlighting common patterns in treatment philosophy seen in other areas of oncology: more selective or patient-tailored treatment strategies, refined protocols and -whenever possible- tissue sparing and minimally invasive surgical interventions.

  • The feasibility and outcome of nephron-sparing surgery for children with bilateral Wilms tumor. The St Jude Children's Research Hospital experience: 1999-2006. . 2008. Cancer 112 2060-70.
  • Ultrasonography underestimates the volume of normal parenchyma in benign testicular masses. . 2007. J Urol 178 1730-2.
  • A case of renal cell carcinoma after success-ful treatment of Wilms tumor. . 2010. J Pediatr Surg 45 1883-6.